Y-27632 2HCl是一种选择性的ROCK1(p160ROCK)抑制剂,Ki为140 nM,比对其他激酶包括PKC,cAMP依赖性蛋白激酶, MLCK和PAK的作用强200多倍。同时,Y-27632能与Thiazovivin提高重编程效率,促进iPSCs的产生。此外,Y-27632还能抑制LPA 诱导的细胞套亡(entosis)。
别名:Y27632; Y-27632 2HCl
Y-27632 2HCl是一种选择性的ROCK1(p160ROCK)抑制剂,Ki为140 nM,比对其他激酶包括PKC,cAMP依赖性蛋白激酶, MLCK和PAK的作用强200多倍。Y-27632也同等有效抑制ROCK-II。Y-27632作用于PKC, cAMP依赖的蛋白激酶和 肌球蛋白轻链激酶(MLCK)几乎没有活性,Ki分别为26 μM, 25 μM, 和 > 250 μM。Y-27632通过选择性抑制Ca2+敏感化,而抑制多种兴奋剂而不是KCl,包括Phenylephrine, Histamine, Acetylcholine, Serotonin, Endothelin,和Thromboxane诱导的平滑肌收缩,IC50为0.3-1 μM。此外,Y-27632能与Thiazovivin提高重编程效率,促进iPSCs的产生。此外,Y-27632还能抑制LPA 诱导的细胞套亡(entosis)。
Nature. 2024 Jul 24;632(8024):411-418.
In vivo interaction screening reveals liver-derived constraints to metastasis
Cancer Cell. 2024 Mar 11;42(3):487-496.
Cell. 2024 Feb 1;187(3):712-732.e38.
Human fetal brain self-organizes into long-term expanding organoids
Nat Immunol. 2024 Apr 25;25(5):790-801.
Cell Stem Cell. 2024 Jan;S1934-5909(23)00438-1.
Human conjunctiva organoids to study ocular surface homeostasis and disease
Nat Metab. 2024 Aug 27;6(8):1529-1548.
The unique catalytic properties of PSAT1 mediate metabolic adaptation to glutamine blockade
Sci Transl Med. 2024 Apr 3;16(741):eadj5705.
Nat Commun. 2024 Feb;15(1):1200.
Nat Commun. 2024 May 13;15(1):4034.
J Exp Med. 2024 Feb;221(3):e20231237.
Cell Rep Med. 2024 Oct 15;5(10):101777.
Modeling lung adenocarcinoma metastases using patient-derived organoids
J Exp Clin Cancer Res. 2024 Feb 27;43(1):61.
J Exp Clin Cancer Res. 2024 Mar 19;43(1):85.
Anaplastic thyroid cancer spheroids as preclinical models to test therapeutics
Proc Natl Acad Sci U S A. 2024 Mar 19;121(12):e2309902121.
Epidermal growth factor receptor (EGFR) is a target of the tumor-suppressor E3 ligase FBXW7
EMBO Mol Med. 2024 Jun 3.
A multispectral 3D live organoid imaging platform to screen probes for fluorescence guided surgery
J Immunother Cancer. 2024 Mar 21;12(3):e007538.
Cancer Lett. 2024 Oct 02;605:217284.
Cell Rep. 2024 Jan;43(1):113614.
Cell Rep. 2024 Apr 23;43(4):114019.
Derivation of functional thymic epithelial organoid lines from adult murine thymus
Materials Today Bio. 2024 Sep 29;29:101262.
Biofabrication. 2024 Aug 07;16(4).
Cancer Biology. 2024 May.
The transcriptional landscape of metastatic hormone-naïve prostate cancer
Int J Cancer. 2024 Mar 27.
J Cell Mol Med. 2024 May;28(9):e18374.
Clin Epigenetics. 2024 Nov 10;16(1):156.
Cell Rep Methods. 2024 Jun 16.
Scientific Reports. 2024 Jun 26;14(7):999.
Virchows Archiv. 2024 Jul 09;28(7):e18190.
Head and Neck Pathology . 2024 Jul 02;20(4):e1011945.
J Mammary Gland Biol Neoplasia. 2024 May 2.
biorxiv. 2024 Mar 26.
Infection of human organoids supports an intestinal niche for Chlamydia trachomatis
biorxiv. 2024 Mar 15.
Tuft cells act as regenerative stem cells in the human intestine
STAR Protoc. 2024 Jul 15;5(3):103189.
STAR Protoc. 2024 Oct 01.
Protocol for culturing patient-derived organoids of cervical cancer
BioRxiv. 2024 Nov 09.
NovumRNA: accurate prediction of non-canonical tumor antigens from RNA sequencing data
Nutrients. 2024 May 14;2023.02.24.529893.
Cell and Tissue Biology. 2024 Jun;Volume 18, 296-306.
Interaction of pRb and β-Catenin in Cancer and Normal Human Prostate Tissue
4 Medizinische Fakultät. 2024 Sep 03.
Nat Biotechnol. 2023 Feb 23.
Cancer Cell. 2023 Nov 13;41(11):1945-1962.e11.
Cancer Cell. 2023 Dec 11;41(12):2083-2099.e9.
Cell Res. 2023 Jun;33(6):464-478.
Signal Transduct Target Ther. 2023 May 19;8(1):187.
FBXW7β loss-of-function enhances FASN-mediated lipogenesis and promotes colorectal cancer growth
Nat Commun. 2023 May 27;14(1):3074.
Nat Commun. 2023 Jul 13;14(1):4193.
ACTL6A protects gastric cancer cells against ferroptosis through induction of glutathione synthesis
Nat Commun. 2023 Nov 28;14(1):7361.
Nat Commun. 2023 Jun 16;14(1):3469.
J Exp Med. 2023 Nov 6;220(11):e20211743.
MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer
Adv Sci (Weinh). 2023 Jul 23;e2302640.
Sci Adv. 2023 Aug 2;9(31):eadf3566.
PHF8-GLUL axis in lipid deposition and tumor growth of clear cell renal cell carcinoma
Sci Adv. 2023 Oct 6;9(40):eadf6911.
Proc Natl Acad Sci U S A. 2023 Feb 7;120(6):e2216836120.
Adv Healthc Mater. 2023 May 22;e2300666.
Gut Microbes. 2023 Jan-Dec;15(1):2186114.
Therapeutic potential of Clostridium butyricum anticancer effects in colorectal cancer
Cell Rep. 2023 Dec ;43(1):113614.
Tubuloid differentiation to model the human distal nephron and collecting duct in health and disease
Cell Rep. 2023 Dec;43, 113614.
Tubuloid differentiation to model the human distal nephron and collecting duct in health and disease
Elife. 2023 May 11;12:e83867.
High-grade serous ovarian carcinoma organoids as models of chromosomal instability
Oncogene. 2023 Aug 17.
Persistent organic pollutants promote aggressiveness in prostate cancer
NPJ Precis Oncol. 2023 Nov 2;7(1):112.
Cell Commun Signal. 2023 Jan 23;21(1):22.
Extracellular matrix stiffness mediates uterine repair via the Rap1a/ARHGAP35/RhoA/F-actin/YAP axis
Breast Cancer Res. 2023 Aug 4;25(1):91.
Int J Radiat Oncol Biol Phys. 2023 Oct 9;S0360-3016(23)07970-1.
Radiosensitization by hyperthermia critically depends on the time interval
Int J Cancer. 2023 Aug 25.
Int J Mol Sci. 2023 Feb 1;24(3):2830.
Int J Mol Sci. 2023 Jul 4;24(13):11048.
iScience. 2023 Jul 3.
Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors
iScience. 2023 Sep 27;26(10):108076.
Front Endocrinol (Lausanne). 2023 Mar 13;14:1140888.
Establishment of papillary thyroid cancer organoid lines from clinical specimens
Chem Biol Interact. 2023 Dec 1;386:110777.
Inflamm Bowel Dis. 2023 Feb 1;29(2):195-206.
Breast Cancer Res Treat. 2023 May 19.
Organoid models derived from patients with malignant phyllodes tumor of the breast
Eur J Pharm Sci. 2023 May 25;106481.
BMC Cancer. 2023 Aug 8;23(1):732.
iScience. 2023 Nov 4;26(12):108399.
PLoS One. 2023 Jan 5;18(1):e0279821.
Vet Comp Oncol. 2023 Mar;21(1):111-122.
Animal Model Exp Med. 2023 Oct;6(5):409-418.
Prev Nutr Food Sci. 2023 Sep 30;28(3):360-369.
bioRxiv. 2023 Aug 26;2023.02.24.529893.
STAR Protoc. 2023 Nov 20;4(4):102735.
Nature. 2022 Aug;608(7923):609-617.
Truncated FGFR2 is a clinically actionable oncogene in multiple cancers
Nat Biotechnol. 2022 Jul 25.
Uncovering the mode of action of engineered T cells in patient cancer organoids
Mol Cancer. 2022 Mar 18;21(1):77.
Cell Stem Cell. 2022 Aug 19;S1934-5909(22)00338-1.
Optimized human intestinal organoid model reveals interleukin-22-dependency of paneth cell formation
Nat Commun. 2022 Apr 4;13(1):1804.
Loss of Rnf31 and Vps4b sensitizes pancreatic cancer to T cell-mediated killing
Nat Commun. 2022 Jul 28;13(1):4364.
Nat Commun. 2022 May 13;13(1):2672.
Nat Commun. 2022 Jul 9;13(1):3998.
Nat Commun. 2022 Oct 5;13(1):5878.
Helicobacter pylori shows tropism to gastric differentiated pit cells dependent on urea chemotaxis
Adv Sci (Weinh). 2022 May;9(13):e2104301.
Self‐Organization of Tissue Growth by Interfacial Mechanical Interactions in Multilayered Systems
J Extracell Vesicles. 2022 Nov;11(11):e12280.
Small. 2022 Jan;18(2):e2104328.
Topographic Cues Guiding Cell Polarization via Distinct Cellular Mechanosensing Pathways
Cancer Res. 2022 Feb 18;canres.CAN-21-2807-E.2021.
Proc Natl Acad Sci U S A. 2022 Nov 16;119(46):e2212057119.
EMBO Mol Med. 2022 Sep 7;14(9):e15687.
Fundamental Research. 2022 June 3;2022;12:37.
Cell Rep. 2022 Mar 1;38(9):110438.
BMP gradient along the intestinal villus axis controls zonated enterocyte and goblet cell states
Cell Rep. 2022 Aug 23;40(8):111266.
SF3B1 facilitates HIF1-signaling and promotes malignancy in pancreatic cancer
J Nanobiotechnology. 2022 Jul 15;20(1):326.
Differentiated kidney tubular cell-derived extracellular vesicles enhance maturation of tubuloids
Cell Mol Gastroenterol Hepatol. 2022;13(3):681-694.
Microbiol Spectr. 2022 Jun 29;10(3):e0105522.
NPJ Breast Cancer. 2022 Jul 12;8(1):81.
Commun Biol. 2022 Oct 14;5(1):1095.
Commun Biol. 2022 Oct 14;5(1):1094.
Commun Biol. 2022 Oct 28;5(1):1144.
Live slow-frozen human tumor tissues viable for 2D, 3D, ex vivo cultures and single-cell RNAseq
Int J Mol Sci. 2022 Jan 24;23(3):1286.
Unravelling Mechanisms of Doxorubicin-Induced Toxicity in 3D Human Intestinal Organoids
Neoplasia. 2022 May;27:100784.
Inhibition of HDACs reduces Ewing sarcoma tumor growth through EWS-FLI1 protein destabilization
iScience. 2022 Jan 6;25(2):103736.
iScience. 2022 Jan;25(2):103736.
Front Bioeng Biotechnol. 2022 Mar 1;10:820930.
Dis Model Mech. 2022 May 1;15(5):dmm049379.
Journal of Ovarian Research. 2022 Apr.
Using Genetically Encoded Fluorescent Biosensors to Interrogate Ovarian Cancer Metabolism
Cancers (Basel). 2022 May 19;14(10):2508.
Dynamic Visualization of TGF-β/SMAD3 Transcriptional Responses in Single Living Cells
Appl Biochem Biotechnol Appl Biochem Biotechnol. 2022 Jul 1.
STAR Protoc. 2022 Jul 31;3(3):101597.
Protocols to culture and harvest hepatic tumor organoids for metabolic assays
STAR Protoc. 2022 Aug 18;3(3):101639.
Differentiation and CRISPR-Cas9-mediated genetic engineering of human intestinal organoids
J Vis Exp. 2022 Feb 12.
Establishment and Genetic Manipulation of Murine Hepatocyte Organoids
STAR Protoc. 2022 Jan 10;3(1):101079.
Utrecht University. 2022.
The beginning of a new life: characterizing somatic mutation accumulation in fetal stem cells
Cell Stem Cell. 2021 Jul 1;28(7):1221-1232.e7.
Exploring the human lacrimal gland using organoids and single-cell sequencing
Nat Commun. 2021 Jun 23;12(1):3896.
Nat Commun. 2021 Sep 17;12(1):5498.
Nat Commun. 2021 Mar 3;12(1):1407.
Somatic mutations and single-cell transcriptomes reveal the root of malignant rhabdoid tumours
Adv Sci (Weinh). 2021 Jan 6;8(4):2003205.
Nat Protoc. 2021 Oct;16(10):4633-4649.
Proceedings of the National Academy of Sciences. 2021 Dec 16;118 (51) e2117017118.
Proceedings of the National Academy of Sciences. 2021.
Bacterially produced R-spondin3 increases Hepatocyte Proliferation Independent of Liver Zonation
EMBO Mol Med. 2021 Jul 7;13(7):e13067.
Cysteamine-bicalutamide combination therapy corrects proximal tubule phenotype in cystinosis
Proc Natl Acad Sci U S A. 2021 Feb 16;118(7):e2017115118.
Nature Protocols. 2021 Jan;16(1):182-217.
Cell Rep. 2021 Mar 9;34(10):108819.
Cell Rep. 2021 Jul 20;36(3):109351.
Cell Rep. 2021 Aug 24;36(8):109568.
Cell Rep. 2021 Jul 20;36(3):109351.
Adv Healthc Mater. 2021 Aug;10(16):e2100821.
Cell Death Dis. 2021 Jan 18;12(1):95.
EMBO Reports. 2021 Oct 25;22:e52058.
Modelling of Primary Ciliary Dyskinesia using Patient-derived Airway Organoids
EMBO Rep. 2021 Dec 6;22(12):e52058.
Modelling of primary ciliary dyskinesia using patient-derived airway organoids
Nanoscale. 2021 May 13;13(18):8614-8622.
Ordered inverse-opal scaffold based on bionic transpiration to create a biomimetic spine
J Clin Endocrinol Metab. 2021 Apr 23;106(5):1410-1426.
Organoid Cultures Derived From Patients With Papillary Thyroid Cancer
Sci Rep. 2021 Apr 15;11(1):8206.
Interleukin-37 regulates innate immune signaling in human and mouse colonic organoids
Chem Eng Sci. 2021 Jul 20;Volume 238, 116632.
Microfluidic droplets as structural templates for Matrigel to enable 1-week large organoid modeling
Cancer Biol Med. 2021 Mar 12;18(3):750-762.
Mol Hum Reprod. 2021 May 29;27(6):gaab033.
Two alternative methods for the retrieval of somatic cell populations from the mouse ovary
Biochem Biophys Res Commun. 2021 Oct 8;573:151-157.
Human embryonic stem cell-derived melanocytes exhibit limited immunogenicity
STAR Protoc. 2021 Dec 8;2(4):100997.
Generation of mixed murine organoids to model cellular interactions
bioRxiv. 2021 May 6;442764.
Behavioral-transcriptomic landscape of engineered T cells targeting human cancer organoids
bioRxiv. 2021 Mar 9.
c-Myc plays a key role in IFN-γ induced persistence of Chlamydia trachomatis
JOURNAL OF SHANGHAI JIAO TONG UNIVERSITY (MEDICAL SCIENCE). 2021;41(8):1017-1024.
Establishment and optimization of co-culture technology for breast cancer organoids
Universiteit Utrecht. 2021 Apr.
Nature. 2020 Apr;580(7802):269-273.
Mutational Signature in Colorectal Cancer Caused by Genotoxic Pks + E. Coli
Nature. 2020 Dec;588(7839):664-669.
Creation of bladder assembloids mimicking tissue regeneration and cancer
Cell. 2020 Jan 23;180(2):233-247.e21.
Cell. 2020 May 7;S0092-8674(20)30501-8.
High-Resolution mRNA and Secretome Atlas of Human Enteroendocrine Cells
Cell Res. 2020 Feb;30(2):163-178.
ILF3 is a substrate of SPOP for regulating serine biosynthesis in colorectal cancer.
Nat Microbiol. 2020 Nov;5(11):1390-1402.
Nat Biomed Eng. 2020 Sep;4(9):863-874.
High-throughput automated organoid culture via stem-cell aggregation in microcavity arrays
Nat Biomed Eng. 2020 Sep;4(9):875-888.
Cell Stem Cell. 2020 Mar 5;26(3):431-440.e8.
Genome-Scale CRISPR Screening in Human Intestinal Organoids Identifies Drivers of TGF-β Resistance
Cell Stem Cell. 2020 Apr 2;26(4):503-510.e7.
CRISPR-Based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid Biobank
Cell Stem Cell. 2020 Apr 2;26(4):569-578.e7.
Plasticity of Lgr5-Negative Cancer Cells Drives Metastasis in Colorectal Cancer
Cell Stem Cell. 2020 Nov 5;27(5):840-851.e6.
Next-Generation Surrogate Wnts Support Organoid Growth and Deconvolute Frizzled Pleiotropy In Vivo
Nat Commun. 2020 May 19;11(1):2493.
The Mutational Impact of Culturing Human Pluripotent and Adult Stem Cells
Nat Commun. 2020 Mar 11;11(1):1310.
An Organoid Biobank for Childhood Kidney Cancers That Captures Disease and Tissue Heterogeneity
Nat Commun. 2020 Dec 22;11(1):6438.
MaTAR25 lncRNA regulates the Tensin1 gene to impact breast cancer progression
Nat Commun. 2020 Sep 15;11(1):4629.
Adv Sci (Weinh). 2020 Jul 26;7(18):2001797.
Polyisocyanide Hydrogels as a Tunable Platform for Mammary Gland Organoid Formation
Nat Protoc. 2020 Oct;15(10):3380-3409.
Establishment of patient-derived cancer organoids for drug-screening applications
Cancer Res. 2020 Apr 1;80(7):1486-1497.
Genome Res. 2020 Sep;30(9):1258-1273.
Environ Health Perspect. 2020 Jun;128(6):67008.
Elife. 2020 Apr 21;9:e52511.
Biofabrication. 2020 May 19.
Use of Inkjet-Printed Single Cells to Quantify Intratumoral Heterogeneity
PLoS Pathog. 2020 Apr 13;16(4):e1008498.
Br J Cancer. 2020 May;122(11):1673-1685.
CSN6-TRIM21 Axis Instigates Cancer Stemness During Tumorigenesis
Sci Rep. 2020 Jul 31;10(1):12991.
Sci Rep. 2020 Dec 8;10(1):21475.
Development of a human primary gut-on-a-chip to model inflammatory processes
Cancer Cell Int. 2020 Mar 18;20:86.
Breast Cancer Organoids From a Patient With Giant Papillary Carcinoma as a High-Fidelity Model
Infect Immun. 2020 Apr 13;IAI.00017-20.
PLoS One. 2020 May 18;15(5):e0231588.
STAR Protocols. 2020 Jun 19;Volume 1, Issue 1.
ACS Appl. Bio Mater. 2020 Sep;9, 6273–6283.
Rapid Microfluidic Formation of Uniform Patient-Derived Breast Tumor Spheroids
Curr Protoc Immunol. 2020 Sep;130(1):e106.
Establishment and Culture of Human Intestinal Organoids Derived from Adult Stem Cells
Cell Rep Med. 2020 Dec 22;1(9):100161.
An Automated Organoid Platform with Inter-organoid Homogeneity and Inter-patient Heterogeneity
STAR Protoc. 2020 Dec 28;2(1):100239.
Protocol for generation of lung adenocarcinoma organoids from clinical samples
STAR Protoc. 2020 Dec 4;1(3):100192.
Establishment of Pancreatic Organoids from Normal Tissue and Tumors
Nat Med. 2019 May;25(5):838-849.
An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity.
Nat Biotechnol. 2019 Mar;37(3):303-313.
Tubuloids derived from human adult kidney and urine for personalized disease modeling.
Cancer Discov. 2019 Jul;9(7):852-871.
Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy.
Nat Commun. 2019 Aug 23;10(1):3800.
Rebalancing of actomyosin contractility enables mammary tumor formation upon loss of E-cadherin.
Proc Natl Acad Sci U S A. 2019 Dec 9.
Pancreatic cancer organoids recapitulate disease and allow personalized drug screening.
Cell Mol Life Sci. 2019 Dec 14.
Biol Proced Online. 2019 Jun 15;21:12.
Establishment and Morphological Characterization of Patient-Derived Organoids from Breast Cancer.
Cell. 2018 Jan 11;172(1-2):373-386.e10.
A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity
Cell. 2018 Nov 29;175(6):1591-1606.e19.
Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids.
Adv Mater. 2018 Sep 10;e1801621.
Nat Microbiol. 2018 Jul;3(7):814-823.
Modelling Cryptosporidium infection in human small intestinal and lung organoids.
Cancer Discov. 2018 Sep 13.
Prediction of DNA Repair Inhibitor Response in Short Term Patient-Derived Ovarian Cancer Organoids.
Nat Protoc. 2018 Jan;13(1):59-78.
Nat Protoc. 2018 Feb;13(2):235-247.
Oncotarget. 2017 Dec 28;9(12):10375-10387.
Mater Sci Eng C Mater Biol Appl. 2017 Sep 1;78:443-451.
Am J Clin Exp Urol. 2017 Nov 9;5(3):25-33.
Organoid culture of human prostate cancer cell lines LNCaP and C4-2B
Nature. 2016 Nov 24;539(7630):560-564.
Designer matrices for intestinal stem cell and organoid culture
Nat Protoc. 2016 Feb;347-58.
Organoid culture systems for prostate epithelial and cancer tissue.
Natl Med J China. 2015 Nov 3;Vol. 95, No.41 3373-3377.
Section Infection and Immunity. .
Role of the proto-oncogene c-Myc in the development of Chlamydia trachomatis
数据来源 | Nature (2016). Figure 1. Y-27632 (Abmole Bioscience Inc) | |
方法 | Cell culture. | |
细胞系/动物模型 | single cells | |
浓度 | 10 μM | |
处理时间 | ||
实验结果 |
体外实验* | |
---|---|
细胞系 | cyES cells |
方法 | For 5-bromo-2′-deoxyuridine (BrdU) incorporation assays, dissociated cyES cells were seeded at a concentration of 500 cells/cm2 onto fresh feeder layers in the presence of the ROCK inhibitors Y-27632 (Wako Pure Chemical Industries, Tokyo, Japan) or Fasudil (Tocris Bioscience, MO, USA) during the first 24 h of culture. The BrdU incorporation assay was performed using colorimetric BrdU Cell proliferation Kit (Roche Diagnostics) according to the manufacturer's instructions. BrdU incorporations were also observed by immunocytochemical (ICC) staining with BrdU Labeling and Detection Kit I (Roche Diagnostics). |
浓度 | 0, 0.1, 0.5, 5, 10, 20µM |
处理时间 | 24 h |
*上述方法来自公开文献,仅供相同目的实验参考。如实验目的、材料、方法不同,请参考其他文献。
体内实验* | |
---|---|
动物模型 | EAC modeling |
配制 | dissolved in 0.9% NaCl |
剂量 | 0.1, 1, 10 mg/kg/day for 14 days |
给药处理 | i.p. |
*上述方法来自公开文献,仅供相同目的实验参考。如实验目的、材料、方法不同,请参考其他文献。
分子量 | 320.26 |
分子式 | C14H21N3O.2HCl |
CAS号 | 129830-38-2 |
溶解性(25°C) | Water ≥ 60 mg/mL DMSO ≥ 35 mg/mL |
储存条件 |
粉末型式 -20°C 3年;4°C 2年 溶于溶剂 -80°C 6个月;-20°C 1个月 |
运输方式 | 冰袋运输,根据产品的不同,可能会有相应调整。 |
*下述溶液配置方法仅为基于分子量计算出的理论值。不同产品在配置溶液前,需考虑其在不同溶剂中的溶解度限制。
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 3.1225 mL | 15.6123 mL | 31.2246 mL |
5 mM | 0.6245 mL | 3.1225 mL | 6.2449 mL |
10 mM | 0.3122 mL | 1.5612 mL | 3.1225 mL |
小鼠 | 大鼠 | 兔 | 豚鼠 | 仓鼠 | 狗 | |
重量 (kg) | 0.02 | 0.15 | 1.8 | 0.4 | 0.08 | 10 |
体表面积 (m2) | 0.007 | 0.025 | 0.15 | 0.05 | 0.02 | 0.5 |
Km 系数 | 3 | 6 | 12 | 8 | 5 | 20 |
动物 A (mg/kg) = 动物 B (mg/kg) × | 动物 B的Km系数 |
动物 A的Km系数 |
例如,依据体表面积折算法,将化合物用于小鼠的剂量20 mg/kg 换算成大鼠的剂量,需要将20 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到化合物用于大鼠的等效剂量为10 mg/kg。
其他相关的ROCK产品 |
---|
OXA-06 hydrochloride
OXA-06 hydrochloride 是一种 ATP 竞争性的 ROCK 抑制剂,能够阻断非小细胞肺癌细胞系的贴壁依赖性生长和侵袭。OXA-06 hydrochloride 抑制丝切蛋白磷酸化,但不刺激细胞凋亡。 |
Y-33075 hydrochloride
Y-33075 hydrochloride (Y-39983) 是选择性ROCK抑制剂,由 Y-27632 衍生而来,,IC50 为 3.6 nM,比 Y-27632 更有效。 |
SR-3677 dihydrochloride
SR-3677 dihydrochloride 是一种有效的选择性 ROCK-II 和 ROCK-II 抑制剂,其 IC50 为 56 nM 和 3 nM。 |
Akt/ROCK-IN-1
Akt/ROCK-IN-1 (B12) 是 Akt 和 ROCK 的双重抑制剂,IC50 分别为 0.023 nM 和 1.47 nM。 |
Scaff10-8
Scaff10-8与RhoA结合,抑制了AKAP-Lbc-mediatedRhoA介导的RhoA活化。 |
产品仅供科学研究或药证申报的用途使用,不为任何个人或者非科研性质的其他用途提供服务。
Copyright © 2010-2022 AbMole版权所有 沪ICP备16047849号 沪公网安备 31011502012228号